Mr. Chen is the Managing Partner for Clearbridge Partners, an Asian venture capital firm. He is also the Managing Partner for Clearbridge Accelerator, a Singapore National Research Foundation (NRF) backed high-technology incubator and an investment committee member of Clearbridge BSA Pte Ltd.

Prior to founding Clearbridge, Mr. Chen worked at Pacific Century CyberWorks Limited, the incumbent and leading telecommunications company in Hong Kong. Mr. Chen is a member of the pioneering team at PCCW and was the President of CyberWorks Ventures, the Venture Capital and direct investment arm of PCCW. Mr. Chen was also the youngest member of PCCW’s Mergers Acquisitions executive committee, and was responsible for much of PCCW’s strategic expansion and many of its successful acquisitions and investments.

Mr. Chen has more than 12 years of entrepreneurship experience with start-ups, being the co-founder of 2 start-up companies with successful exits. Mr. Chen has also given talks on entrepreneurship in Hong Kong and the United States, including the Sloan School of Management at MIT. Mr. Chen is an active angel investor and was a member of the Hong Kong Science and Technology Park (HKSTP) incubator selection panel and a venture committee member of the Hong Kong Venture Capital and Private Equity Association (HKVCA). He is also currently a member of the Singapore NRF POC grant panel.

Mr. Chen is the recipient of the prestigious Sword of Honour from the Singapore Armed Forces, and holds a B.A., M.A. and M.Eng from the University of Cambridge, (U.K.).

Mr. Chong previously worked as a Communications Security Program Manager at the DSO National Laboratories. He won the prestigious KINETIC Award in DSO for his outstanding technical contributions to various initiatives in the defence sector. He oversaw various cryptographic and communication systems as well as direct research & development investments in excess of S$5 million annually. He was also the key technical decision maker on various national level projects.

Prior to working at DSO, Mr. Chong was with the Directorate of Research & Development (under the Defence Science & Technology Agency) as a Country Manager, where he was responsible for the long term strategic R&D plans for the Ministry of Defence. Mr Chong was also the Assistant Director of Finance Policy at the Ministry of Health (MOH) where his responsibilities included policy matters on Singapore’s key medical financial schemes.

Mr. Chong is the recipient of the Public Service Commission’s Local Merit Scholarship and has a B.Eng and M.Eng (Electrical Engineering) from the National University of Singapore.

Mr. Qian was the vice president, the director of public affairs and the secretary of the Board of Trauson Holdings Company Limited. Mr. Qian graduated from Simon Fraser University in Canada with both BBA and MBA degrees. He is now a registered senior economist. He serves as a member of Changzhou Municipal Chinese People’s Political Consultative Conference (CPPCC). Mr. Qian brings with him a wealth of experience in IPO and M&A, where he was responsible for project coordination and legal affairs, along with corporate re-organisation.

Mr. Chua joined the former Singapore Technologies Group in 1987 where he was involved in the early phase of Singapore Technologies’ venture capital investments which became Vertex in 1988. Throughout his career in Vertex, he has been involved in investments globally particularly in the US, Singapore, Taiwan, China and Israel. He spent several years in the US from 1989 to 1992 and later from 1998 to 2004 where he was head of Vertex US office. Mr. Chua currently heads Vertex’s investment in India, Singapore, Korea and SE Asia.

Prior to Singapore Technologies Group, Mr. Chua was with the NatSteel Group where he was involved in venture capital investments and corporate project development activities. He worked in the Singapore Economic Development Board and the Singapore subsidiary of General Electric’s semiconductor division after graduating from the University of Singapore in 1979 with a Bachelor of Engineering (Mechanical). He also has a MBA from National University of Singapore.

Mr. Chua currently serves on the Board of muvee Technologies Pte Ltd, eGInnovations Pte Ltd, Reverse Logistic Co. Pvt Ltd, Anhui Bayi Chemical Co Ltd and Shandong Huaan New Materials Co Ltd. His past directorships include UTAC, Spreadtrum Communication, Silknet and others. He is also currently a member of both the Evaluation Panel for NRF POC Grant Scheme and the Advisory Board/Selection Committee of SMART Innovation Center.

Dr. Fu is a General Partner of Bioveda Capital, a venture capital firm focused exclusively on investments in healthcare and biotechnology.

She has more than ten years of clinical experience with a focus on internal medicine, and has practiced in the Singapore General Hospital, National University Hospital and in a group practice in the United States. She does investments through a family office in Kuo International Pte Ltd and is a director of Kuo Investments Ltd. In her own personal capacity, she does angel investments in early start-up companies.

Dr. Fu received her B.S. in Biology from Columbia University, New York and her M.D. from the University of Southern California. She is certified with the American Board of Internal Medicine and is also a registered physician with the Singapore Medical Council.

ACTC 2017 [click me]


Learn More
AMP 2017 [click me]


Learn More
Contact Us for more information